Updated:
Vivozon
Vivozon was established in 2008 by Doo-Lee Lee in Yongin-si, South Korea. The company functions as both a drug developer and corporate investor, concentrating...
Vivozon
Vivozon was established in 2008 by Doo-Lee Lee in Yongin-si, South Korea. The company functions as both a drug developer and corporate investor, concentrating resources on pharmaceutical raw materials and finished products. Its investment approach spans seed, start-up, and late-stage venture commitments. Capital supports internal programs and external opportunities in pain medicine and central nervous system therapies. Geographic reach includes South Korea headquarters and plant operations plus a New Jersey office. Confirmed partners include Telcon RF Pharmaceutical through prior strategic arrangements. The firm employs an estimated 66 million dollars in assets. It maintains two South Korean sites and one U.S. location. Vivozon lists donations to the Community Chest of Korea and the International Vaccine Institute. Ownership remains tied to founder Lee Doohyun with no disclosed external governance vehicles or succession structures beyond direct corporate control.
General information
Firm type
Corporate Investor
Year founded
2008
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Yongin-si
Corporate office
Yongin-si, Gyeonggi-do, South Korea
Additional offices
Hwaseong, Gyeonggi-do, South Korea · West Windsor, NJ, United States
Principals
Doo-Lee Lee
Founder, Chairman, and CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Vivozon?
Doo-Lee Lee serves as Founder, Chairman, and CEO and directs investment activity.
What asset classes does Vivozon deploy into?
Vivozon commits to early-stage seed, start-up, and expansion venture opportunities in pharmaceuticals.
Does Vivozon maintain facilities outside South Korea?
Yes. It operates a West Windsor, New Jersey office in addition to its Yongin-si headquarters and Hwaseong plant.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: